Notice: ICH Guidance on Reporting Adverse Reactions to Marketed Health Products
Health Canada has implemented the International Council for Harmonisation of Technical Requirements of Pharmaceuticals for Human Use (ICH) Guidance: E2D Post-Approval Safety Data Management: Definitions and Standards for Expedited Reporting via our Guidance Document for Industry - Reporting Adverse Reactions to Marketed Health Products, which took effect on March 3, 2011.
- Publisher - Current Organization Name: Health Canada
- Licence: Open Government Licence - Canada
Data and Resources
-
Notice: ICH Guidance on Reporting Adverse Reactions to Marketed Health ProductsHTMLEnglish publication HTML
-
Notice: ICH Guidance on Reporting Adverse Reactions to Marketed Health ProductsHTMLFrench publication HTML
Similar records